Why Chuy's Holdings Shares Are Trading Higher By 47%; Here Are 20 Stocks Moving Premarket
Portfolio Pulse from Avi Kapoor
Shares of Chuy’s Holdings, Inc. (NASDAQ:CHUY) surged 47.4% in pre-market trading after announcing that Darden Restaurants, Inc. (NYSE:DRI) will acquire Chuy's for $37.50 per share in cash, valuing the deal at approximately $605 million. Other notable pre-market movers include Onconetix, Inc. (NASDAQ:ONCO), Apollomics, Inc. (NASDAQ:APLM), and Leslie’s, Inc. (NASDAQ:LESL).
July 18, 2024 | 10:00 am
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Leslie’s shares fell 22.6% in pre-market trading after issuing preliminary third-quarter financial results below estimates and cutting FY24 guidance.
The disappointing financial results and reduced guidance have negatively impacted investor sentiment, leading to a significant drop in Leslie’s stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 50
POSITIVE IMPACT
Apollomics shares rose 30.4% in pre-market trading after receiving a 180-day extension from Nasdaq to address non-compliance with listing requirements.
The extension from Nasdaq provides Apollomics with more time to regain compliance, which has positively impacted investor sentiment.
CONFIDENCE 70
IMPORTANCE 60
RELEVANCE 50
POSITIVE IMPACT
Chuy’s Holdings shares surged 47.4% in pre-market trading following the announcement of its acquisition by Darden Restaurants for $37.50 per share in cash.
The acquisition announcement at a premium price has significantly boosted investor confidence, leading to a sharp rise in CHUY's stock price.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100
POSITIVE IMPACT
Darden Restaurants announced the acquisition of Chuy’s Holdings for $37.50 per share in cash, valuing the deal at approximately $605 million.
The acquisition is likely to be viewed positively as it expands Darden's portfolio, potentially leading to a short-term increase in DRI's stock price.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100
POSITIVE IMPACT
Onconetix shares gained 65% in pre-market trading after announcing the closing of a warrant exercise for $1.11 million in gross proceeds.
The successful warrant exercise has provided Onconetix with additional capital, boosting investor confidence and driving the stock price higher.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 50